| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022969 |
| Receipt No. | R000026479 |
| Official scientific title of the study | Deep brain stimulation(DBS) for intractable obsessive-compulsive disorders(OCDs). randomized crossover trial and open-label trial |
| Date of disclosure of the study information | 2016/07/07 |
| Last modified on | 2016/07/01 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Deep brain stimulation(DBS) for intractable obsessive-compulsive disorders(OCDs).
randomized crossover trial and open-label trial |
|
| Title of the study (Brief title) | Deep brain stimulation for intractable obsessive-compulsive disorders (DBS for OCDs) | |
| Region |
|
|
| Condition | |||
| Condition | Intractable obsessive-compulsive disorders | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Observe the efficacy of DBS of the bilateral anterior internal capsule/ ventral striatum (AIC/VS-DBS) for intractable OCDs |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | more than 35% improvement of Yale Brown Obsessive Compulsive Scale (Y-BOCS) at 12 months after the initiation of AIC/VS-DBS. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Deep brain stimulation group | |
| Interventions/Control_2 | Sham deep brain stimulation group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 20 to 70 year-old OCD patients diagnosed by DSM-5 with the informed consent.
Y-BOCS score of 30/40 or more and Global Assessment of Functioning scores of 45 or less. Refractory against medication and cognitive behavioral therapy for more than 5 years. |
|||
| Key exclusion criteria | Other psychiatric illness (autism, schizophrenia, bipolar disorders, depression, drug addiction), and brain disease (epilepsy, trauma, cerebro-vascular disease, neuro-degenerative disease) except tic and Tourette syndrome.
Severe cardiac diseases, pulmonary diseases blood diseases Pregnant or during breast-feeding. Whom researchers judged as inappropriate |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Kenji Sugiyama |
| Organization | Hamamatsu University School of Medicine |
| Division name | Department of Neurosurgery |
| Address | 1-20-1, Handa-yama, Higashi-ku, Hamamatsu |
| TEL | 053-435-2283 |
| kesugi@hama-med.ac.jp | |
| Public contact | |
| Name of contact person | Kenji Sugiyama |
| Organization | Hamamatsu University School of Medicine |
| Division name | Department of Neurosurgery |
| Address | 1-20-1, Handa-yama, Higashi-ku, Hamamatsu |
| TEL | 053-435-2283 |
| Homepage URL | |
| kesugi@hama-med.ac.jp | |
| Sponsor | |
| Institute | Hamamatsu University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Hamamatsu University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026479 |